David Snow

David Snow joined Regeneron in 2020 and is Senior Vice President and Global Head of the Dupixent® (dupilumab) franchise. Prior to working at Regeneron, Mr. Snow built his expertise at various pharmaceutical and healthcare companies including AstraZeneca, Bristol Myers Squibb, Eloxx Pharmaceuticals and Radius Health. He received his BS of Marketing at Auburn University and his MBA at New York University.